nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—ABCB1—lung cancer	0.202	1	CbGaD
Loratadine—CYP2C19—Gefitinib—lung cancer	0.03	0.053	CbGbCtD
Loratadine—CYP2C19—Teniposide—lung cancer	0.0291	0.0514	CbGbCtD
Loratadine—ABCB1—Topotecan—lung cancer	0.0265	0.0468	CbGbCtD
Loratadine—CYP2C9—Gefitinib—lung cancer	0.0249	0.0441	CbGbCtD
Loratadine—ABCB1—Gefitinib—lung cancer	0.0242	0.0428	CbGbCtD
Loratadine—CYP2C9—Teniposide—lung cancer	0.0242	0.0427	CbGbCtD
Loratadine—CYP2D6—Gefitinib—lung cancer	0.0228	0.0403	CbGbCtD
Loratadine—CYP2C8—Erlotinib—lung cancer	0.0211	0.0374	CbGbCtD
Loratadine—CYP2C8—Paclitaxel—lung cancer	0.0194	0.0342	CbGbCtD
Loratadine—ABCB1—Vinorelbine—lung cancer	0.0186	0.0329	CbGbCtD
Loratadine—CYP2D6—Vinorelbine—lung cancer	0.0176	0.031	CbGbCtD
Loratadine—CYP3A4—Topotecan—lung cancer	0.0159	0.028	CbGbCtD
Loratadine—CYP2C8—Etoposide—lung cancer	0.0153	0.027	CbGbCtD
Loratadine—ABCB1—Crizotinib—lung cancer	0.0148	0.0262	CbGbCtD
Loratadine—CYP3A4—Gefitinib—lung cancer	0.0145	0.0256	CbGbCtD
Loratadine—ABCB1—Gemcitabine—lung cancer	0.0145	0.0256	CbGbCtD
Loratadine—ABCB1—Erlotinib—lung cancer	0.0143	0.0253	CbGbCtD
Loratadine—CYP3A4—Teniposide—lung cancer	0.0141	0.0249	CbGbCtD
Loratadine—CYP2C9—Paclitaxel—lung cancer	0.0135	0.0239	CbGbCtD
Loratadine—CYP2D6—Erlotinib—lung cancer	0.0135	0.0238	CbGbCtD
Loratadine—ABCB1—Paclitaxel—lung cancer	0.0131	0.0232	CbGbCtD
Loratadine—ABCB1—Irinotecan—lung cancer	0.0129	0.0228	CbGbCtD
Loratadine—ABCB1—Vinblastine—lung cancer	0.0115	0.0203	CbGbCtD
Loratadine—CYP3A4—Vinorelbine—lung cancer	0.0112	0.0197	CbGbCtD
Loratadine—CYP2C9—Cisplatin—lung cancer	0.0109	0.0192	CbGbCtD
Loratadine—CYP2D6—Vinblastine—lung cancer	0.0108	0.0191	CbGbCtD
Loratadine—ABCB1—Cisplatin—lung cancer	0.0105	0.0186	CbGbCtD
Loratadine—ABCB1—Etoposide—lung cancer	0.0104	0.0183	CbGbCtD
Loratadine—ABCB1—Docetaxel—lung cancer	0.00947	0.0167	CbGbCtD
Loratadine—CYP3A4—Crizotinib—lung cancer	0.00889	0.0157	CbGbCtD
Loratadine—CYP3A4—Erlotinib—lung cancer	0.00857	0.0152	CbGbCtD
Loratadine—CYP3A4—Paclitaxel—lung cancer	0.00785	0.0139	CbGbCtD
Loratadine—CYP3A4—Irinotecan—lung cancer	0.00774	0.0137	CbGbCtD
Loratadine—ABCB1—Doxorubicin—lung cancer	0.00706	0.0125	CbGbCtD
Loratadine—CYP3A4—Vinblastine—lung cancer	0.00688	0.0122	CbGbCtD
Loratadine—ABCB1—Methotrexate—lung cancer	0.00684	0.0121	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—lung cancer	0.00665	0.0118	CbGbCtD
Loratadine—CYP3A4—Etoposide—lung cancer	0.0062	0.011	CbGbCtD
Loratadine—CYP3A4—Docetaxel—lung cancer	0.00567	0.01	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—lung cancer	0.00423	0.00748	CbGbCtD
Loratadine—Immune system disorder—Docetaxel—lung cancer	0.000198	0.0013	CcSEcCtD
Loratadine—Headache—Erlotinib—lung cancer	0.000198	0.0013	CcSEcCtD
Loratadine—Loss of consciousness—Paclitaxel—lung cancer	0.000198	0.0013	CcSEcCtD
Loratadine—Paraesthesia—Gemcitabine—lung cancer	0.000197	0.00129	CcSEcCtD
Loratadine—Cough—Paclitaxel—lung cancer	0.000196	0.00129	CcSEcCtD
Loratadine—Asthenia—Vinorelbine—lung cancer	0.000196	0.00128	CcSEcCtD
Loratadine—Arrhythmia—Docetaxel—lung cancer	0.000196	0.00128	CcSEcCtD
Loratadine—Chest pain—Etoposide—lung cancer	0.000195	0.00128	CcSEcCtD
Loratadine—Nausea—Vinblastine—lung cancer	0.000195	0.00128	CcSEcCtD
Loratadine—Somnolence—Gemcitabine—lung cancer	0.000195	0.00128	CcSEcCtD
Loratadine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000194	0.00127	CcSEcCtD
Loratadine—Hypertension—Paclitaxel—lung cancer	0.000194	0.00127	CcSEcCtD
Loratadine—Fatigue—Irinotecan—lung cancer	0.000194	0.00127	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000194	0.00127	CcSEcCtD
Loratadine—Alopecia—Docetaxel—lung cancer	0.000193	0.00127	CcSEcCtD
Loratadine—Discomfort—Etoposide—lung cancer	0.000193	0.00127	CcSEcCtD
Loratadine—Pain—Irinotecan—lung cancer	0.000192	0.00126	CcSEcCtD
Loratadine—Constipation—Irinotecan—lung cancer	0.000192	0.00126	CcSEcCtD
Loratadine—Chest pain—Paclitaxel—lung cancer	0.000191	0.00126	CcSEcCtD
Loratadine—Myalgia—Paclitaxel—lung cancer	0.000191	0.00126	CcSEcCtD
Loratadine—Hypotension—Cisplatin—lung cancer	0.000191	0.00125	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.00019	0.00125	CcSEcCtD
Loratadine—Nausea—Topotecan—lung cancer	0.000189	0.00124	CcSEcCtD
Loratadine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000189	0.00124	CcSEcCtD
Loratadine—Discomfort—Paclitaxel—lung cancer	0.000189	0.00124	CcSEcCtD
Loratadine—Fatigue—Gemcitabine—lung cancer	0.000189	0.00124	CcSEcCtD
Loratadine—Pain—Gemcitabine—lung cancer	0.000187	0.00123	CcSEcCtD
Loratadine—Constipation—Gemcitabine—lung cancer	0.000187	0.00123	CcSEcCtD
Loratadine—Nausea—Erlotinib—lung cancer	0.000187	0.00123	CcSEcCtD
Loratadine—Dry mouth—Paclitaxel—lung cancer	0.000187	0.00123	CcSEcCtD
Loratadine—Anaphylactic shock—Etoposide—lung cancer	0.000187	0.00123	CcSEcCtD
Loratadine—Diarrhoea—Vinorelbine—lung cancer	0.000187	0.00122	CcSEcCtD
Loratadine—Dysgeusia—Docetaxel—lung cancer	0.000187	0.00122	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000186	0.00122	CcSEcCtD
Loratadine—Feeling abnormal—Irinotecan—lung cancer	0.000185	0.00122	CcSEcCtD
Loratadine—Gastrointestinal pain—Irinotecan—lung cancer	0.000184	0.00121	CcSEcCtD
Loratadine—Anaphylactic shock—Paclitaxel—lung cancer	0.000183	0.0012	CcSEcCtD
Loratadine—Paraesthesia—Cisplatin—lung cancer	0.000183	0.0012	CcSEcCtD
Loratadine—Tachycardia—Etoposide—lung cancer	0.000183	0.0012	CcSEcCtD
Loratadine—Skin disorder—Etoposide—lung cancer	0.000182	0.00119	CcSEcCtD
Loratadine—Feeling abnormal—Gemcitabine—lung cancer	0.000181	0.00119	CcSEcCtD
Loratadine—Shock—Paclitaxel—lung cancer	0.00018	0.00118	CcSEcCtD
Loratadine—Dizziness—Vinorelbine—lung cancer	0.00018	0.00118	CcSEcCtD
Loratadine—Abdominal pain upper—Doxorubicin—lung cancer	0.00018	0.00118	CcSEcCtD
Loratadine—Nervous system disorder—Paclitaxel—lung cancer	0.00018	0.00118	CcSEcCtD
Loratadine—Tachycardia—Paclitaxel—lung cancer	0.000179	0.00118	CcSEcCtD
Loratadine—Skin disorder—Paclitaxel—lung cancer	0.000178	0.00117	CcSEcCtD
Loratadine—Body temperature increased—Irinotecan—lung cancer	0.000178	0.00117	CcSEcCtD
Loratadine—Abdominal pain—Irinotecan—lung cancer	0.000178	0.00117	CcSEcCtD
Loratadine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000176	0.00116	CcSEcCtD
Loratadine—Drowsiness—Methotrexate—lung cancer	0.000176	0.00115	CcSEcCtD
Loratadine—Depression—Methotrexate—lung cancer	0.000175	0.00115	CcSEcCtD
Loratadine—Hypotension—Etoposide—lung cancer	0.000175	0.00115	CcSEcCtD
Loratadine—Gastritis—Doxorubicin—lung cancer	0.000175	0.00115	CcSEcCtD
Loratadine—Pain—Cisplatin—lung cancer	0.000175	0.00115	CcSEcCtD
Loratadine—Vomiting—Vinorelbine—lung cancer	0.000173	0.00114	CcSEcCtD
Loratadine—Body temperature increased—Gemcitabine—lung cancer	0.000173	0.00114	CcSEcCtD
Loratadine—Rash—Vinorelbine—lung cancer	0.000172	0.00113	CcSEcCtD
Loratadine—Dermatitis—Vinorelbine—lung cancer	0.000172	0.00113	CcSEcCtD
Loratadine—Hypotension—Paclitaxel—lung cancer	0.000171	0.00113	CcSEcCtD
Loratadine—Headache—Vinorelbine—lung cancer	0.000171	0.00112	CcSEcCtD
Loratadine—Syncope—Docetaxel—lung cancer	0.000171	0.00112	CcSEcCtD
Loratadine—Palpitations—Docetaxel—lung cancer	0.000168	0.00111	CcSEcCtD
Loratadine—Feeling abnormal—Cisplatin—lung cancer	0.000168	0.0011	CcSEcCtD
Loratadine—Paraesthesia—Etoposide—lung cancer	0.000168	0.0011	CcSEcCtD
Loratadine—Loss of consciousness—Docetaxel—lung cancer	0.000167	0.0011	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000167	0.0011	CcSEcCtD
Loratadine—Somnolence—Etoposide—lung cancer	0.000166	0.00109	CcSEcCtD
Loratadine—Cough—Docetaxel—lung cancer	0.000166	0.00109	CcSEcCtD
Loratadine—Hepatobiliary disease—Methotrexate—lung cancer	0.000166	0.00109	CcSEcCtD
Loratadine—Insomnia—Paclitaxel—lung cancer	0.000166	0.00109	CcSEcCtD
Loratadine—Epistaxis—Methotrexate—lung cancer	0.000166	0.00109	CcSEcCtD
Loratadine—Paraesthesia—Paclitaxel—lung cancer	0.000165	0.00108	CcSEcCtD
Loratadine—Hypertension—Docetaxel—lung cancer	0.000164	0.00108	CcSEcCtD
Loratadine—Somnolence—Paclitaxel—lung cancer	0.000163	0.00107	CcSEcCtD
Loratadine—Chest pain—Docetaxel—lung cancer	0.000162	0.00106	CcSEcCtD
Loratadine—Myalgia—Docetaxel—lung cancer	0.000162	0.00106	CcSEcCtD
Loratadine—Nausea—Vinorelbine—lung cancer	0.000162	0.00106	CcSEcCtD
Loratadine—Gastrointestinal disorder—Etoposide—lung cancer	0.000162	0.00106	CcSEcCtD
Loratadine—Dyspepsia—Paclitaxel—lung cancer	0.000161	0.00106	CcSEcCtD
Loratadine—Body temperature increased—Cisplatin—lung cancer	0.000161	0.00106	CcSEcCtD
Loratadine—Asthenia—Irinotecan—lung cancer	0.000161	0.00106	CcSEcCtD
Loratadine—Fatigue—Etoposide—lung cancer	0.000161	0.00106	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000161	0.00106	CcSEcCtD
Loratadine—Pain—Etoposide—lung cancer	0.00016	0.00105	CcSEcCtD
Loratadine—Constipation—Etoposide—lung cancer	0.00016	0.00105	CcSEcCtD
Loratadine—Dry mouth—Docetaxel—lung cancer	0.000159	0.00104	CcSEcCtD
Loratadine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000158	0.00104	CcSEcCtD
Loratadine—Fatigue—Paclitaxel—lung cancer	0.000158	0.00104	CcSEcCtD
Loratadine—Pollakiuria—Doxorubicin—lung cancer	0.000158	0.00103	CcSEcCtD
Loratadine—Asthenia—Gemcitabine—lung cancer	0.000157	0.00103	CcSEcCtD
Loratadine—Pain—Paclitaxel—lung cancer	0.000157	0.00103	CcSEcCtD
Loratadine—Constipation—Paclitaxel—lung cancer	0.000157	0.00103	CcSEcCtD
Loratadine—Pharyngitis—Methotrexate—lung cancer	0.000157	0.00103	CcSEcCtD
Loratadine—Anaphylactic shock—Docetaxel—lung cancer	0.000155	0.00102	CcSEcCtD
Loratadine—Feeling abnormal—Etoposide—lung cancer	0.000154	0.00101	CcSEcCtD
Loratadine—Diarrhoea—Irinotecan—lung cancer	0.000154	0.00101	CcSEcCtD
Loratadine—Gastrointestinal pain—Etoposide—lung cancer	0.000153	0.001	CcSEcCtD
Loratadine—Shock—Docetaxel—lung cancer	0.000153	0.001	CcSEcCtD
Loratadine—Nervous system disorder—Docetaxel—lung cancer	0.000152	0.001	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—lung cancer	0.000152	0.000999	CcSEcCtD
Loratadine—Tachycardia—Docetaxel—lung cancer	0.000152	0.000996	CcSEcCtD
Loratadine—Feeling abnormal—Paclitaxel—lung cancer	0.000151	0.000992	CcSEcCtD
Loratadine—Skin disorder—Docetaxel—lung cancer	0.000151	0.000991	CcSEcCtD
Loratadine—Gastrointestinal pain—Paclitaxel—lung cancer	0.00015	0.000985	CcSEcCtD
Loratadine—Diarrhoea—Gemcitabine—lung cancer	0.00015	0.000984	CcSEcCtD
Loratadine—Dizziness—Irinotecan—lung cancer	0.000149	0.000976	CcSEcCtD
Loratadine—Body temperature increased—Etoposide—lung cancer	0.000148	0.000971	CcSEcCtD
Loratadine—Abdominal pain—Etoposide—lung cancer	0.000148	0.000971	CcSEcCtD
Loratadine—Tinnitus—Methotrexate—lung cancer	0.000147	0.000965	CcSEcCtD
Loratadine—Asthenia—Cisplatin—lung cancer	0.000147	0.000962	CcSEcCtD
Loratadine—Hypotension—Docetaxel—lung cancer	0.000145	0.000954	CcSEcCtD
Loratadine—Abdominal pain—Paclitaxel—lung cancer	0.000145	0.000952	CcSEcCtD
Loratadine—Body temperature increased—Paclitaxel—lung cancer	0.000145	0.000952	CcSEcCtD
Loratadine—Hepatobiliary disease—Doxorubicin—lung cancer	0.000144	0.000945	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—lung cancer	0.000144	0.000942	CcSEcCtD
Loratadine—Vomiting—Irinotecan—lung cancer	0.000143	0.000939	CcSEcCtD
Loratadine—Immune system disorder—Methotrexate—lung cancer	0.000142	0.000935	CcSEcCtD
Loratadine—Rash—Irinotecan—lung cancer	0.000142	0.000931	CcSEcCtD
Loratadine—Dermatitis—Irinotecan—lung cancer	0.000142	0.00093	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000142	0.00093	CcSEcCtD
Loratadine—Headache—Irinotecan—lung cancer	0.000141	0.000925	CcSEcCtD
Loratadine—Insomnia—Docetaxel—lung cancer	0.000141	0.000923	CcSEcCtD
Loratadine—Diarrhoea—Cisplatin—lung cancer	0.00014	0.000917	CcSEcCtD
Loratadine—Paraesthesia—Docetaxel—lung cancer	0.00014	0.000917	CcSEcCtD
Loratadine—Alopecia—Methotrexate—lung cancer	0.000139	0.000915	CcSEcCtD
Loratadine—Vomiting—Gemcitabine—lung cancer	0.000139	0.000914	CcSEcCtD
Loratadine—Somnolence—Docetaxel—lung cancer	0.000138	0.000907	CcSEcCtD
Loratadine—Rash—Gemcitabine—lung cancer	0.000138	0.000907	CcSEcCtD
Loratadine—Dermatitis—Gemcitabine—lung cancer	0.000138	0.000906	CcSEcCtD
Loratadine—Headache—Gemcitabine—lung cancer	0.000137	0.000901	CcSEcCtD
Loratadine—Dyspepsia—Docetaxel—lung cancer	0.000137	0.000898	CcSEcCtD
Loratadine—Pharyngitis—Doxorubicin—lung cancer	0.000136	0.00089	CcSEcCtD
Loratadine—Dysgeusia—Methotrexate—lung cancer	0.000134	0.000883	CcSEcCtD
Loratadine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000134	0.000881	CcSEcCtD
Loratadine—Asthenia—Etoposide—lung cancer	0.000134	0.000881	CcSEcCtD
Loratadine—Fatigue—Docetaxel—lung cancer	0.000134	0.00088	CcSEcCtD
Loratadine—Nausea—Irinotecan—lung cancer	0.000134	0.000877	CcSEcCtD
Loratadine—Pain—Docetaxel—lung cancer	0.000133	0.000873	CcSEcCtD
Loratadine—Constipation—Docetaxel—lung cancer	0.000133	0.000873	CcSEcCtD
Loratadine—Asthenia—Paclitaxel—lung cancer	0.000132	0.000864	CcSEcCtD
Loratadine—Nausea—Gemcitabine—lung cancer	0.00013	0.000854	CcSEcCtD
Loratadine—Vomiting—Cisplatin—lung cancer	0.00013	0.000852	CcSEcCtD
Loratadine—Rash—Cisplatin—lung cancer	0.000129	0.000845	CcSEcCtD
Loratadine—Dermatitis—Cisplatin—lung cancer	0.000129	0.000844	CcSEcCtD
Loratadine—Feeling abnormal—Docetaxel—lung cancer	0.000128	0.000841	CcSEcCtD
Loratadine—Diarrhoea—Etoposide—lung cancer	0.000128	0.00084	CcSEcCtD
Loratadine—Ill-defined disorder—Methotrexate—lung cancer	0.000127	0.000836	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—lung cancer	0.000127	0.000836	CcSEcCtD
Loratadine—Gastrointestinal pain—Docetaxel—lung cancer	0.000127	0.000835	CcSEcCtD
Loratadine—Diarrhoea—Paclitaxel—lung cancer	0.000126	0.000824	CcSEcCtD
Loratadine—Malaise—Methotrexate—lung cancer	0.000124	0.000813	CcSEcCtD
Loratadine—Dizziness—Etoposide—lung cancer	0.000124	0.000812	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—lung cancer	0.000123	0.00081	CcSEcCtD
Loratadine—Body temperature increased—Docetaxel—lung cancer	0.000123	0.000807	CcSEcCtD
Loratadine—Abdominal pain—Docetaxel—lung cancer	0.000123	0.000807	CcSEcCtD
Loratadine—Arrhythmia—Doxorubicin—lung cancer	0.000122	0.000801	CcSEcCtD
Loratadine—Dizziness—Paclitaxel—lung cancer	0.000121	0.000796	CcSEcCtD
Loratadine—Nausea—Cisplatin—lung cancer	0.000121	0.000796	CcSEcCtD
Loratadine—Alopecia—Doxorubicin—lung cancer	0.000121	0.000792	CcSEcCtD
Loratadine—Cough—Methotrexate—lung cancer	0.00012	0.000787	CcSEcCtD
Loratadine—Vomiting—Etoposide—lung cancer	0.000119	0.000781	CcSEcCtD
Loratadine—Rash—Etoposide—lung cancer	0.000118	0.000774	CcSEcCtD
Loratadine—Dermatitis—Etoposide—lung cancer	0.000118	0.000774	CcSEcCtD
Loratadine—Headache—Etoposide—lung cancer	0.000117	0.000769	CcSEcCtD
Loratadine—Chest pain—Methotrexate—lung cancer	0.000117	0.000767	CcSEcCtD
Loratadine—Myalgia—Methotrexate—lung cancer	0.000117	0.000767	CcSEcCtD
Loratadine—Tension—Doxorubicin—lung cancer	0.000117	0.000766	CcSEcCtD
Loratadine—Vomiting—Paclitaxel—lung cancer	0.000117	0.000766	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—lung cancer	0.000116	0.000764	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000116	0.000762	CcSEcCtD
Loratadine—Rash—Paclitaxel—lung cancer	0.000116	0.000759	CcSEcCtD
Loratadine—Dermatitis—Paclitaxel—lung cancer	0.000116	0.000759	CcSEcCtD
Loratadine—Discomfort—Methotrexate—lung cancer	0.000115	0.000758	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—lung cancer	0.000115	0.000758	CcSEcCtD
Loratadine—Headache—Paclitaxel—lung cancer	0.000115	0.000754	CcSEcCtD
Loratadine—Anaphylactic shock—Methotrexate—lung cancer	0.000112	0.000736	CcSEcCtD
Loratadine—Asthenia—Docetaxel—lung cancer	0.000112	0.000732	CcSEcCtD
Loratadine—Nausea—Etoposide—lung cancer	0.000111	0.00073	CcSEcCtD
Loratadine—Ill-defined disorder—Doxorubicin—lung cancer	0.00011	0.000724	CcSEcCtD
Loratadine—Nervous system disorder—Methotrexate—lung cancer	0.00011	0.000721	CcSEcCtD
Loratadine—Agitation—Doxorubicin—lung cancer	0.000109	0.000717	CcSEcCtD
Loratadine—Nausea—Paclitaxel—lung cancer	0.000109	0.000715	CcSEcCtD
Loratadine—Skin disorder—Methotrexate—lung cancer	0.000109	0.000715	CcSEcCtD
Loratadine—Malaise—Doxorubicin—lung cancer	0.000107	0.000704	CcSEcCtD
Loratadine—Syncope—Doxorubicin—lung cancer	0.000107	0.0007	CcSEcCtD
Loratadine—Diarrhoea—Docetaxel—lung cancer	0.000106	0.000698	CcSEcCtD
Loratadine—Palpitations—Doxorubicin—lung cancer	0.000105	0.00069	CcSEcCtD
Loratadine—Hypotension—Methotrexate—lung cancer	0.000105	0.000687	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—lung cancer	0.000104	0.000686	CcSEcCtD
Loratadine—Cough—Doxorubicin—lung cancer	0.000104	0.000681	CcSEcCtD
Loratadine—Dizziness—Docetaxel—lung cancer	0.000103	0.000675	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—lung cancer	0.000103	0.000674	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000102	0.00067	CcSEcCtD
Loratadine—Insomnia—Methotrexate—lung cancer	0.000101	0.000665	CcSEcCtD
Loratadine—Chest pain—Doxorubicin—lung cancer	0.000101	0.000664	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—lung cancer	0.000101	0.000664	CcSEcCtD
Loratadine—Paraesthesia—Methotrexate—lung cancer	0.000101	0.000661	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000101	0.00066	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—lung cancer	0.0001	0.000657	CcSEcCtD
Loratadine—Somnolence—Methotrexate—lung cancer	9.96e-05	0.000654	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—lung cancer	9.9e-05	0.00065	CcSEcCtD
Loratadine—Vomiting—Docetaxel—lung cancer	9.89e-05	0.000649	CcSEcCtD
Loratadine—Dyspepsia—Methotrexate—lung cancer	9.86e-05	0.000648	CcSEcCtD
Loratadine—Rash—Docetaxel—lung cancer	9.8e-05	0.000644	CcSEcCtD
Loratadine—Dermatitis—Docetaxel—lung cancer	9.79e-05	0.000643	CcSEcCtD
Loratadine—Headache—Docetaxel—lung cancer	9.74e-05	0.000639	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—lung cancer	9.7e-05	0.000637	CcSEcCtD
Loratadine—Gastrointestinal disorder—Methotrexate—lung cancer	9.67e-05	0.000635	CcSEcCtD
Loratadine—Fatigue—Methotrexate—lung cancer	9.66e-05	0.000634	CcSEcCtD
Loratadine—Pain—Methotrexate—lung cancer	9.58e-05	0.000629	CcSEcCtD
Loratadine—Shock—Doxorubicin—lung cancer	9.55e-05	0.000627	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—lung cancer	9.52e-05	0.000625	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—lung cancer	9.47e-05	0.000622	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—lung cancer	9.43e-05	0.000619	CcSEcCtD
Loratadine—Nausea—Docetaxel—lung cancer	9.24e-05	0.000606	CcSEcCtD
Loratadine—Feeling abnormal—Methotrexate—lung cancer	9.23e-05	0.000606	CcSEcCtD
Loratadine—Gastrointestinal pain—Methotrexate—lung cancer	9.16e-05	0.000602	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—lung cancer	9.07e-05	0.000595	CcSEcCtD
Loratadine—Abdominal pain—Methotrexate—lung cancer	8.86e-05	0.000582	CcSEcCtD
Loratadine—Body temperature increased—Methotrexate—lung cancer	8.86e-05	0.000582	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—lung cancer	8.84e-05	0.00058	CcSEcCtD
Loratadine—Insomnia—Doxorubicin—lung cancer	8.78e-05	0.000576	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—lung cancer	8.71e-05	0.000572	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—lung cancer	8.63e-05	0.000566	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—lung cancer	8.54e-05	0.000561	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—lung cancer	8.38e-05	0.00055	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—lung cancer	8.37e-05	0.000549	CcSEcCtD
Loratadine—Constipation—Doxorubicin—lung cancer	8.3e-05	0.000545	CcSEcCtD
Loratadine—Pain—Doxorubicin—lung cancer	8.3e-05	0.000545	CcSEcCtD
Loratadine—Asthenia—Methotrexate—lung cancer	8.04e-05	0.000528	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—lung cancer	8e-05	0.000525	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—lung cancer	7.93e-05	0.000521	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—lung cancer	7.67e-05	0.000504	CcSEcCtD
Loratadine—Body temperature increased—Doxorubicin—lung cancer	7.67e-05	0.000504	CcSEcCtD
Loratadine—Diarrhoea—Methotrexate—lung cancer	7.67e-05	0.000503	CcSEcCtD
Loratadine—Dizziness—Methotrexate—lung cancer	7.41e-05	0.000486	CcSEcCtD
Loratadine—Vomiting—Methotrexate—lung cancer	7.13e-05	0.000468	CcSEcCtD
Loratadine—Rash—Methotrexate—lung cancer	7.07e-05	0.000464	CcSEcCtD
Loratadine—Dermatitis—Methotrexate—lung cancer	7.06e-05	0.000463	CcSEcCtD
Loratadine—Headache—Methotrexate—lung cancer	7.02e-05	0.000461	CcSEcCtD
Loratadine—Asthenia—Doxorubicin—lung cancer	6.96e-05	0.000457	CcSEcCtD
Loratadine—Nausea—Methotrexate—lung cancer	6.66e-05	0.000437	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—lung cancer	6.64e-05	0.000436	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—lung cancer	6.42e-05	0.000421	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—lung cancer	6.17e-05	0.000405	CcSEcCtD
Loratadine—Rash—Doxorubicin—lung cancer	6.12e-05	0.000402	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—lung cancer	6.11e-05	0.000401	CcSEcCtD
Loratadine—Headache—Doxorubicin—lung cancer	6.08e-05	0.000399	CcSEcCtD
Loratadine—Nausea—Doxorubicin—lung cancer	5.76e-05	0.000378	CcSEcCtD
Loratadine—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.01e-05	0.000126	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.01e-05	0.000126	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NQO1—lung cancer	1.01e-05	0.000125	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.97e-06	0.000124	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.97e-06	0.000124	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTT1—lung cancer	9.95e-06	0.000124	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAP2K1—lung cancer	9.92e-06	0.000124	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ENO1—lung cancer	9.9e-06	0.000123	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	9.89e-06	0.000123	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—RRM1—lung cancer	9.87e-06	0.000123	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTA3—lung cancer	9.87e-06	0.000123	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTT1—lung cancer	9.86e-06	0.000123	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.86e-06	0.000123	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CD—lung cancer	9.86e-06	0.000123	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2A6—lung cancer	9.84e-06	0.000122	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GCLC—lung cancer	9.84e-06	0.000122	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.77e-06	0.000122	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GCLC—lung cancer	9.75e-06	0.000121	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2A6—lung cancer	9.75e-06	0.000121	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.71e-06	0.000121	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AVP—lung cancer	9.49e-06	0.000118	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CB—lung cancer	9.46e-06	0.000118	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ENO1—lung cancer	9.32e-06	0.000116	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—B4GALT5—lung cancer	9.28e-06	0.000116	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	9.25e-06	0.000115	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ENO1—lung cancer	9.24e-06	0.000115	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.21e-06	0.000115	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF1R—lung cancer	9.13e-06	0.000114	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP2E1—lung cancer	9.09e-06	0.000113	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—CXCL8—lung cancer	9.09e-06	0.000113	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.09e-06	0.000113	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—STK11—lung cancer	9.08e-06	0.000113	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTA4—lung cancer	9.03e-06	0.000112	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NQO1—lung cancer	8.99e-06	0.000112	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HES1—lung cancer	8.97e-06	0.000112	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2E1—lung cancer	8.88e-06	0.000111	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.8e-06	0.00011	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—RAF1—lung cancer	8.8e-06	0.00011	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTA2—lung cancer	8.8e-06	0.00011	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NQO1—lung cancer	8.78e-06	0.000109	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.72e-06	0.000109	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—IL2—lung cancer	8.69e-06	0.000108	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CB—lung cancer	8.59e-06	0.000107	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.52e-06	0.000106	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTA1—lung cancer	8.49e-06	0.000106	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTP1—lung cancer	8.4e-06	0.000105	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCC3—lung cancer	8.39e-06	0.000104	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	8.37e-06	0.000104	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2E1—lung cancer	8.36e-06	0.000104	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2E1—lung cancer	8.29e-06	0.000103	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NQO1—lung cancer	8.27e-06	0.000103	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—CXCL8—lung cancer	8.26e-06	0.000103	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB3—lung cancer	8.2e-06	0.000102	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NQO1—lung cancer	8.2e-06	0.000102	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CAT—lung cancer	8.18e-06	0.000102	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.13e-06	0.000101	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKR1C1—lung cancer	8.13e-06	0.000101	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—STK11—lung cancer	8.1e-06	0.000101	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.03e-06	0.0001	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.95e-06	9.9e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ABCB1—lung cancer	7.95e-06	9.9e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—STK11—lung cancer	7.91e-06	9.85e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL2—lung cancer	7.89e-06	9.83e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—UGT1A1—lung cancer	7.89e-06	9.82e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TERT—lung cancer	7.86e-06	9.79e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—TYMS—lung cancer	7.81e-06	9.73e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTM1—lung cancer	7.72e-06	9.61e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGFR1—lung cancer	7.63e-06	9.51e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.61e-06	9.47e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GNG11—lung cancer	7.61e-06	9.47e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HIF1A—lung cancer	7.52e-06	9.36e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTP1—lung cancer	7.5e-06	9.34e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—STK11—lung cancer	7.45e-06	9.28e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—STK11—lung cancer	7.39e-06	9.2e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTP1—lung cancer	7.32e-06	9.11e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP1A1—lung cancer	7.32e-06	9.11e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CAT—lung cancer	7.3e-06	9.09e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ERCC2—lung cancer	7.26e-06	9.04e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOA1—lung cancer	7.26e-06	9.03e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.26e-06	9.03e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALDOA—lung cancer	7.24e-06	9.02e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KDR—lung cancer	7.19e-06	8.95e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CAT—lung cancer	7.12e-06	8.87e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCB1—lung cancer	7.1e-06	8.84e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOA3—lung cancer	7.03e-06	8.76e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TYMS—lung cancer	6.97e-06	8.68e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.94e-06	8.64e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTP1—lung cancer	6.9e-06	8.59e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTM1—lung cancer	6.89e-06	8.58e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ADCY1—lung cancer	6.84e-06	8.52e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCG2—lung cancer	6.84e-06	8.52e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTP1—lung cancer	6.84e-06	8.51e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TYMS—lung cancer	6.8e-06	8.47e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTM1—lung cancer	6.73e-06	8.38e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CAT—lung cancer	6.71e-06	8.36e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ENO2—lung cancer	6.71e-06	8.35e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HPGDS—lung cancer	6.71e-06	8.35e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPP2R1B—lung cancer	6.67e-06	8.3e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CAT—lung cancer	6.65e-06	8.29e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APC—lung cancer	6.62e-06	8.25e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KIT—lung cancer	6.62e-06	8.25e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CG—lung cancer	6.62e-06	8.25e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—NRAS—lung cancer	6.62e-06	8.25e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.62e-06	8.24e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGF—lung cancer	6.55e-06	8.15e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP1A1—lung cancer	6.53e-06	8.13e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCB1—lung cancer	6.53e-06	8.13e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTT1—lung cancer	6.51e-06	8.1e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ERCC2—lung cancer	6.48e-06	8.07e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCB1—lung cancer	6.47e-06	8.06e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2A6—lung cancer	6.43e-06	8.01e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GCLC—lung cancer	6.43e-06	8.01e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TYMS—lung cancer	6.41e-06	7.98e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP1A1—lung cancer	6.38e-06	7.94e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TYMS—lung cancer	6.36e-06	7.92e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAPK3—lung cancer	6.34e-06	7.9e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTM1—lung cancer	6.34e-06	7.89e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ERCC2—lung cancer	6.32e-06	7.87e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—POMC—lung cancer	6.31e-06	7.85e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTM1—lung cancer	6.28e-06	7.82e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOA1—lung cancer	6.28e-06	7.82e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BRAF—lung cancer	6.23e-06	7.75e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6R—lung cancer	6.15e-06	7.66e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CREBBP—lung cancer	6.14e-06	7.65e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ENO1—lung cancer	6.1e-06	7.59e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—EGFR—lung cancer	6.03e-06	7.51e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.01e-06	7.49e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1A1—lung cancer	6.01e-06	7.48e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ERCC2—lung cancer	5.96e-06	7.42e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1A1—lung cancer	5.96e-06	7.42e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ERCC2—lung cancer	5.91e-06	7.36e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAP2K1—lung cancer	5.86e-06	7.3e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CD—lung cancer	5.82e-06	7.25e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	5.77e-06	7.18e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CG—lung cancer	5.73e-06	7.14e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—KRAS—lung cancer	5.7e-06	7.1e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOA1—lung cancer	5.6e-06	6.98e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOA1—lung cancer	5.47e-06	6.81e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2E1—lung cancer	5.47e-06	6.81e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—POMC—lung cancer	5.46e-06	6.8e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NQO1—lung cancer	5.41e-06	6.73e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.37e-06	6.68e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CREBBP—lung cancer	5.32e-06	6.62e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	5.24e-06	6.52e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MDM2—lung cancer	5.22e-06	6.5e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RAF1—lung cancer	5.2e-06	6.47e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOA1—lung cancer	5.16e-06	6.42e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB2—lung cancer	5.14e-06	6.4e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CG—lung cancer	5.12e-06	6.37e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOA1—lung cancer	5.11e-06	6.36e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CB—lung cancer	5.08e-06	6.32e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MTOR—lung cancer	5.08e-06	6.32e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CD—lung cancer	5.04e-06	6.28e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CG—lung cancer	4.99e-06	6.22e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALB—lung cancer	4.98e-06	6.2e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.89e-06	6.09e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCL8—lung cancer	4.88e-06	6.07e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—STK11—lung cancer	4.87e-06	6.07e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—POMC—lung cancer	4.87e-06	6.07e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—HRAS—lung cancer	4.85e-06	6.03e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—POMC—lung cancer	4.75e-06	5.92e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CREBBP—lung cancer	4.74e-06	5.91e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT1—lung cancer	4.71e-06	5.87e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CG—lung cancer	4.71e-06	5.86e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP3—lung cancer	4.67e-06	5.81e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CG—lung cancer	4.67e-06	5.81e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL2—lung cancer	4.66e-06	5.8e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—lung cancer	4.64e-06	5.78e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CREBBP—lung cancer	4.63e-06	5.77e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCND1—lung cancer	4.54e-06	5.66e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JUN—lung cancer	4.53e-06	5.65e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTP1—lung cancer	4.51e-06	5.62e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CD—lung cancer	4.5e-06	5.6e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—POMC—lung cancer	4.48e-06	5.58e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—POMC—lung cancer	4.44e-06	5.53e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALB—lung cancer	4.44e-06	5.53e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP9—lung cancer	4.41e-06	5.49e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1A—lung cancer	4.4e-06	5.47e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CB—lung cancer	4.39e-06	5.47e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CD—lung cancer	4.39e-06	5.47e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CAT—lung cancer	4.39e-06	5.46e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTEN—lung cancer	4.39e-06	5.46e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CREBBP—lung cancer	4.36e-06	5.43e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—lung cancer	4.35e-06	5.42e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALB—lung cancer	4.33e-06	5.4e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CREBBP—lung cancer	4.33e-06	5.39e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT1—lung cancer	4.28e-06	5.33e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCB1—lung cancer	4.27e-06	5.32e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TYMS—lung cancer	4.19e-06	5.22e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EP300—lung cancer	4.18e-06	5.21e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTM1—lung cancer	4.14e-06	5.16e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CD—lung cancer	4.14e-06	5.15e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CD—lung cancer	4.1e-06	5.11e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALB—lung cancer	4.08e-06	5.09e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SRC—lung cancer	4.07e-06	5.06e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALB—lung cancer	4.05e-06	5.04e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—lung cancer	3.96e-06	4.93e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1A1—lung cancer	3.93e-06	4.89e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—STAT3—lung cancer	3.92e-06	4.88e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CB—lung cancer	3.92e-06	4.88e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NRAS—lung cancer	3.91e-06	4.87e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ERCC2—lung cancer	3.9e-06	4.85e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—lung cancer	3.89e-06	4.84e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CB—lung cancer	3.83e-06	4.77e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTEN—lung cancer	3.8e-06	4.73e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—lung cancer	3.79e-06	4.72e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK3—lung cancer	3.75e-06	4.67e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MYC—lung cancer	3.64e-06	4.54e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—EP300—lung cancer	3.62e-06	4.51e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CB—lung cancer	3.61e-06	4.49e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CB—lung cancer	3.58e-06	4.45e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—lung cancer	3.57e-06	4.45e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGFR—lung cancer	3.57e-06	4.44e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—lung cancer	3.54e-06	4.41e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTEN—lung cancer	3.39e-06	4.22e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOA1—lung cancer	3.37e-06	4.2e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KRAS—lung cancer	3.37e-06	4.19e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTEN—lung cancer	3.31e-06	4.12e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—EP300—lung cancer	3.23e-06	4.02e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—EP300—lung cancer	3.15e-06	3.93e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTEN—lung cancer	3.12e-06	3.88e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CA—lung cancer	3.09e-06	3.85e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTEN—lung cancer	3.09e-06	3.85e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CG—lung cancer	3.08e-06	3.83e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—lung cancer	2.99e-06	3.73e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—EP300—lung cancer	2.97e-06	3.7e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—EP300—lung cancer	2.95e-06	3.67e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—POMC—lung cancer	2.93e-06	3.65e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HRAS—lung cancer	2.86e-06	3.56e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CREBBP—lung cancer	2.85e-06	3.55e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—lung cancer	2.74e-06	3.41e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CD—lung cancer	2.71e-06	3.37e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CA—lung cancer	2.68e-06	3.33e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALB—lung cancer	2.67e-06	3.33e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT1—lung cancer	2.53e-06	3.15e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CA—lung cancer	2.39e-06	2.98e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.36e-06	2.94e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—lung cancer	2.34e-06	2.91e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CA—lung cancer	2.33e-06	2.91e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CA—lung cancer	2.2e-06	2.74e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKT1—lung cancer	2.19e-06	2.72e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CA—lung cancer	2.18e-06	2.71e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTEN—lung cancer	2.04e-06	2.54e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKT1—lung cancer	1.95e-06	2.43e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—EP300—lung cancer	1.94e-06	2.42e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKT1—lung cancer	1.91e-06	2.37e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKT1—lung cancer	1.8e-06	2.24e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKT1—lung cancer	1.78e-06	2.22e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.44e-06	1.79e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKT1—lung cancer	1.17e-06	1.46e-05	CbGpPWpGaD
